Hannah Haylea A, Miramontes Roque, Gandhi Neel R
1 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
2 Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Public Health Rep. 2017 May/Jun;132(3):366-375. doi: 10.1177/0033354917698117. Epub 2017 Apr 10.
The objectives of our study were (1) to determine risk factors associated with tuberculosis (TB)-specific and non-TB-specific mortality among patients with TB and (2) to examine whether risk factors for TB-specific mortality differed from those for non-TB-specific mortality.
We obtained data from the National Tuberculosis Surveillance System and included all patients who had TB between 2009 and 2013 in the United States and its territories. We used multinomial logistic regression analysis to determine the adjusted odds ratio (aOR) of each risk factor for TB-specific and non-TB-specific mortality.
Of 52 175 eligible patients with TB, 1404 died from TB, and 2413 died from other causes. Some of the risk factors associated with the highest odds of TB-specific mortality were multidrug-resistant TB diagnosis (aOR = 3.42; 95% CI, 1.95-5.99), end-stage renal disease (aOR = 3.02; 95% CI, 2.23-4.08), human immunodeficiency virus infection (aOR = 2.63; 95% CI, 2.02-3.42), age 45-64 years (aOR = 2.57; 95% CI, 2.01-3.30) or age ≥65 years (aOR = 5.76; 95% CI, 4.37-7.61), and immunosuppression (aOR = 2.20; 95% CI, 1.71-2.83). All of these risk factors except multidrug-resistant TB were also associated with increased odds of non-TB-specific mortality.
TB patients with certain risk factors have an elevated risk of TB-specific mortality and should be monitored before, during, and after treatment. Identifying the predictors of TB-specific mortality may help public health authorities determine which subpopulations to target and where to allocate resources.
我们研究的目的是(1)确定结核病(TB)患者中与结核病特异性和非结核病特异性死亡率相关的危险因素,以及(2)检查结核病特异性死亡率的危险因素与非结核病特异性死亡率的危险因素是否不同。
我们从国家结核病监测系统获取数据,纳入2009年至2013年在美国及其属地患有结核病的所有患者。我们使用多项逻辑回归分析来确定每个危险因素导致结核病特异性和非结核病特异性死亡率的调整优势比(aOR)。
在52175名符合条件的结核病患者中,1404人死于结核病,2413人死于其他原因。与结核病特异性死亡率最高优势相关的一些危险因素包括耐多药结核病诊断(aOR = 3.42;95% CI,1.95 - 5.99)、终末期肾病(aOR = 3.02;95% CI,2.23 - 4.08)、人类免疫缺陷病毒感染(aOR = 2.63;95% CI,2.02 - 3.42)、45 - 64岁(aOR = 2.57;95% CI,2.01 - 3.30)或年龄≥65岁(aOR = 5.76;95% CI,4.37 - 7.61)以及免疫抑制(aOR = 2.20;95% CI,1.71 - 2.83)。除耐多药结核病外,所有这些危险因素也与非结核病特异性死亡率增加的几率相关。
具有某些危险因素的结核病患者结核病特异性死亡风险升高,应在治疗前、治疗期间和治疗后进行监测。确定结核病特异性死亡率的预测因素可能有助于公共卫生当局确定应针对哪些亚人群以及在何处分配资源。